D-0488-2024 Class II Terminated

Recalled by FDC Limited — Aurangabad, Maharashtra State, N/A

FDA drug recall D-0488-2024 was initiated by FDC Limited on Apr 25, 2024 and is designated Class II. Reason for recall: Defective Container: yellow-colored spike from cap lodged in the nozzle. Firm received several complaints from customers. The recall status is terminated (terminated May 21, 2026). Affected quantity: 382,104 units.

Recall details

Product Type
Drugs
Report Date
May 15, 2024
Initiation Date
Apr 25, 2024
Termination Date
May 21, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
382,104 units

Product description

Timolol Maleate Ophthalmic Solution, USP, 0.5%, packaged in a) 5mL bottles (NDC 64980-514-05), and b) 15 mL bottles (NDC 64980-514-15), Rx only, Manufactured by: FDC Limited, Maharashtra, India, Distributed by: Rising Pharmaceuticals, Inc, NJ

Reason for recall

Defective Container: yellow-colored spike from cap lodged in the nozzle. Firm received several complaints from customers.

Distribution pattern

New Jersey Only

Code information

Lot #: a) 083H008, Exp. Date 07/2025; 083G003, Exp. Date 06/2025; 083J017, Exp. Date 09/2025; b) 083I013, Exp. Date 08/2025.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0488-2024
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0488-2024. Report a data issue: hello@regdatalab.com.